Abstract:BACKGROUND: Colorectal cancer (CRC) is one of the most common tumors worldwide, with approximately 1 million new cases diagnosed in 2000, and accounting for over 500,000 deaths. Novel agents that target specific molecular pathways are needed. A replication-competent adenoviral transduction of manganese superoxide dismutase (MnSOD) inhibited growth of colorectal tumor cells in culture and tumor xenografts in a mouse model (Cancer Research; 2006 in press). Fluorouracil (5-FU) is the most widely used anticancer agent for gastrointestinal cancers, and it is commonly used as adjuvant chemotherapy for colorectal cancer. The aim of this study is to assess the effect of MnSOD gene therapy combined with chemotherapy, on tumor growth and tumor-free survival. METHODS: Nude mice were divided into four groups: PBS control, ZD55-MnSOD injection, 5-FU injection, combined ZD55-MnSOD with 5-FU injection. 5-FU was administered intraperitoneally every other day after four times injection with ZD55-MnSOD. Cell cycles were assayed by FACS. DNA fragmentation, transition electronic microscope and TUNEL assay were used to determine the extent of apoptosis. RESULTS: There was a remarkable decrease in cell viability after colorectal tumor cells were treated with ZD55- MnSOD at various MOI and 5-FU from 24 hours to 72 hours. Enhanced apoptosis in tumor cells receiving the dual therapy was evident as determined by DNA fragmentation analysis, Hoechst 33258 staining, electron microcopy, and a TUNEL assay. Growth of tumor xenografts was significantly inhibited in nude mice 2 months after intratumoral injection of ZD55-MnSOD. The tumor volume decreased significantly in mice after receiving combined injection of ZD55-MnSOD and 5-FU, was much lower than that in mice receiving injections of ZD55-MnSOD or 5-FU alone (80.98±31.76 vs. 792.11±69.70, 1050±435.39 mm3). Moreover, the combined injection of ZD55-MnSOD with 5-FU markedly improved the animal survival, which was better than ZD55-MnSOD or 5-FU alone (66.7% vs. 50% and 33.3%). CONCLUSION: Both ZD55- MnSOD and 5-FU are shown to induce the apoptosis in colorectal tumor cells, while 5-FU potentiated the proapoptotic effect induced by ZD55-MnSOD. It appears that a caspase-dependent pathway is involved in the apoptotic onset in colorectal tumor cells caused by 5-FU or ZD55-MnSOD. Thus, dual adenoviral MnSOD gene therapy plus 5-FU chemotherapy achieved synergetic action in suppressing the tumor growth.

Hyperbaric oxygen therapy increases the effect of 5-fluorouracil chemotherapy on experimental colorectal cancer in mice

Polyunsaturated Fatty Acids Augment Tumoricidal Action Of 5-Fluorouracil On Gastric Cancer Cells By Their Action On Vascular Endothelial Growth Factor, Tumor Necrosis Factor-Alpha And Lipid Metabolism Related Factors

Extremely Effective Chemoradiotherapy by Inducing Immunogenic Cell Death and Radio-Triggered Drug Release under Hypoxia Alleviation

Abstract No. 506 Image-guided Radiofrequency Hyperthermia-Enhanced Direct Chemotherapy of Hepatic Tumors: the Underlying Biomolecular Mechanisms

Effects of FOLFOX Chemotherapy on Tumor Oxygenation and Perfused Vasculature: An In Vivo Study by Optical Techniques

Evaluation of use of hyperbaric oxygen in suppression of hyper-proliferation in hypoxic NSCLC cells

Hyperbaric oxygen enhanced the chemotherapy of mitochondrial targeting molecule IR-780 in bladder cancer

Hyperbaric Oxygen Therapy Represses the Warburg Effect and Epithelial–Mesenchymal Transition in Hypoxic NSCLC Cells via the HIF-1α/PFKP Axis

Enhanced Efficacy of Direct Immunochemotherapy for Hepatic Cancer with Image-Guided Intratumoral Radiofrequency Hyperthermia

5-Fluorouracil Nanoparticles Inhibit Hepatocellular Carcinoma Via Activation of the P53 Pathway in the Orthotopic Transplant Mouse Model

Effects of hypoxia on the growth of gastric cancer and the chemotherapeutic efficacy of 5-fluorouracil

Evaluation of oxidative stress in an experimental model of Crohn's disease treated with hyperbaric oxygen therapy

Helminth-derived molecules improve 5-fluorouracil treatment on experimental colon tumorigenesis

Hyperbaric Oxygen Activates Enzyme‐Driven Cascade Reactions for Cooperative Cancer Therapy and Cancer Stem Cells Elimination

The Treatment of Heterotopic Human Colon Xenograft Tumors in Mice with 5-Fluorouracil Attached to Magnetic Nanoparticles in Combination with Magnetic Hyperthermia Is More Efficient than Either Therapy Alone

Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells

The rational modulation of autophagy sensitizes colorectal cancer cells to 5‐fluouracil and oxaliplatin

Hyperbaric oxygen regulates tumor microenvironment and boosts commercialized nanomedicine delivery for potent eradication of cancer stem-like cells

Impact of 5-Fu/oxaliplatin on Mouse Dendritic Cells and Synergetic Effect with a Colon Cancer Vaccine.

Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model

833. Combined Manganese Superoxide Dismutase Gene Therapy and 5-FU Chemotherapy for Colorectal Cancer